Your browser doesn't support javascript.
loading
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Boudewijns, Steve; Bloemendal, Martine; de Haas, Nienke; Westdorp, Harm; Bol, Kalijn F; Schreibelt, Gerty; Aarntzen, Erik H J G; Lesterhuis, W Joost; Gorris, Mark A J; Croockewit, Alexandra; van der Woude, Lieke L; van Rossum, Michelle M; Welzen, Marieke; de Goede, Anna; Hato, Stanleyson V; van der Graaf, Winette T A; Punt, Cornelis J A; Koornstra, Rutger H T; Gerritsen, Winald R; Figdor, Carl G; de Vries, I Jolanda M.
Afiliación
  • Boudewijns S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bloemendal M; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • de Haas N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Westdorp H; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Bol KF; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Schreibelt G; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands.
  • Aarntzen EHJG; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Lesterhuis WJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Gorris MAJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Croockewit A; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • van der Woude LL; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • van Rossum MM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Welzen M; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • de Goede A; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Hato SV; School of Biomedical Sciences, University of Western Australia, Crawley, Australia.
  • van der Graaf WTA; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Punt CJA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Koornstra RHT; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Gerritsen WR; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Figdor CG; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • de Vries IJM; Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands.
Cancer Immunol Immunother ; 69(3): 477-488, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31980913
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Cisplatino / Vacunas contra el Cáncer / Melanoma Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Cisplatino / Vacunas contra el Cáncer / Melanoma Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos